SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63324 355 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63168FDA was already aware of the patient death in the Phase 1 trial of SRP-9004. Sarghettogoulash1July 18
63167I juat assumed they knew it yesterday. Probably knew it for weeks or a month. Olecranon-July 18
63166They knew this yesterday during conference call: Exclusive-US FDA to ask SareptTripleE3-July 18
63165BRIEF-Sarepta Says 51-Year-Old Male Patient Died In Early Stage Study Of SRP-900luckydog88-July 18
63164agreed - sold the extra I bought this morning, guess I own enough already. justluckydog88-July 18
63163This may be a case of don't try to catch a falling knife....Davidoff1July 18
63162wow - $14 and change pre-market ....... fingers crossed ..... just bought someluckydog88-July 18
63161SRPT 3rd Death from Liver Toxicity A month ago?! After yesterday's confereTripleE3-July 18
63160and a third one came across the wires: Baird analyst Brian Skorney maintains Saluckydog881July 17
63159this one not as positive: RBC Lowers Price Target on Sarepta Therapeutics to $2luckydog88-July 17
63158Needham analyst Gil Blum reiterates Sarepta Therapeutics(SRPT) with a Buy and maluckydog881July 17
63157I didn’t see this announcement in time to see the webcast, but I did read press Olecranon-July 16
63156Just a hunch, but feels like the steps in this release might be step 1 of a planluckydog88-July 16
63155SAREPTA webcast today at 4:30 EST finance.yahoo.com Investor Webcast Details Splhky3465-July 16
63154Had a nice return on that one. Just wish SRPT would turn around.stockdoc771July 10
63153VRNA stockdoc was right folks .... finance.yahoo.complhky3465-July 9
63152Just to clarify the two deaths were in boys receiving therapy that was FDA approstockdoc775June 27
63151Like many here I have followed SRPT for a long time. Several timesI have been tjargonweary2June 26
63150I’m going to give it a little more time. I thought that’s where we were at arounOlecranon-June 26
63149I see this as a contrary indicator. I think the fear/panic trade is mostly donestockdoc77-June 26
63148$10 hahaha. Bring it on. Reminds me of BoA dumping on TGTX the past two years, aghettogoulash-June 26
63147HC Wainwright & Co. analyst Mitchell Kapoor downgrades Sarepta Therapeutics(luckydog881June 25
63146I'm in the same boat and averaged down earlier this year just to get whackedstockdoc773June 23
63145Well dammit, a week ago I was so secure that a SP of upper/mid 30’s was a solid Olecranon3June 18
63144From the WSJ today: New FDA Chief Wants to Fast-Track Some Drugs, Use More AI Cluckydog88-June 17
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):